$2.45 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 95 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 35.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
HZNP | HORIZON THERAPEUTICS PUB LTD | $175,978,000 | +13.2% | 6,462,634 | 0.0% | 7.18% | +28.5% | |
HORIZON PHARMA INVT LTDnote 2.500% 3/1 | $158,106,000 | +5.0% | 136,032,000 | 0.0% | 6.45% | +19.2% | ||
MYL | Buy | MYLAN N V | $151,397,000 | +6.5% | 7,654,065 | +2.5% | 6.17% | +20.9% |
NEVRO CORPnote 1.750% 6/0 | $131,363,000 | +8.9% | 115,776,000 | 0.0% | 5.36% | +23.6% | ||
ORTX | ORCHARD THERAPEUTICS PLCads | $106,012,000 | -15.1% | 8,923,600 | 0.0% | 4.32% | -3.6% | |
FIXX | HOMOLOGY MEDICINES INC | $104,263,000 | -7.5% | 5,760,368 | 0.0% | 4.25% | +5.0% | |
AERI | Buy | AERIE PHARMACEUTICALS INC | $87,813,000 | -2.0% | 4,568,824 | +50.6% | 3.58% | +11.2% |
RYTM | Buy | RHYTHM PHARMACEUTICALS INC | $55,903,000 | +307.2% | 2,589,291 | +315.0% | 2.28% | +362.3% |
BKD | BROOKDALE SR LIVING INC | $54,631,000 | +5.1% | 7,207,239 | 0.0% | 2.23% | +19.3% | |
XENT | INTERSECT ENT INC | $52,884,000 | -25.3% | 3,109,004 | 0.0% | 2.16% | -15.2% | |
XLRN | ACCELERON PHARMA INC | $51,567,000 | -3.8% | 1,305,174 | 0.0% | 2.10% | +9.1% | |
MYOK | Sell | MYOKARDIA INC | $51,182,000 | +2.4% | 981,430 | -1.6% | 2.09% | +16.2% |
INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $49,530,000 | -3.6% | 57,791,000 | 0.0% | 2.02% | +9.4% | ||
IMMU | Sell | IMMUNOMEDICS INC | $42,618,000 | -38.4% | 3,214,000 | -35.5% | 1.74% | -30.0% |
Buy | CLOVIS ONCOLOGY INCnote 2.500% 9/1 | $42,262,000 | +165.8% | 49,064,000 | +172.6% | 1.72% | +201.8% | |
RARX | Buy | RA PHARMACEUTICALS INC | $40,868,000 | -20.7% | 1,728,019 | +0.9% | 1.67% | -9.9% |
MIRM | New | MIRUM PHARMACEUTICALS INC | $34,696,000 | – | 3,448,912 | +100.0% | 1.42% | – |
Sell | KEMPHARM INCnote 5.500% 2/0 | $32,179,000 | +1.7% | 62,423,000 | -4.6% | 1.31% | +15.5% | |
ARGX | ARGENX SEsponsored adr | $32,023,000 | -19.5% | 281,000 | 0.0% | 1.31% | -8.6% | |
SILK | Buy | SILK ROAD MEDICAL INC | $31,862,000 | +31.8% | 979,480 | +96.3% | 1.30% | +49.5% |
VCEL | Buy | VERICEL CORP | $31,506,000 | -19.4% | 2,081,000 | +0.6% | 1.28% | -8.5% |
CHRS | Sell | COHERUS BIOSCIENCES INC | $31,207,000 | -15.8% | 1,540,305 | -8.2% | 1.27% | -4.5% |
CNC | Buy | CENTENE CORP DEL | $31,165,000 | +96.1% | 720,400 | +137.8% | 1.27% | +122.6% |
FATE | Buy | FATE THERAPEUTICS INC | $30,328,000 | -12.3% | 1,952,897 | +14.7% | 1.24% | -0.5% |
ALEC | Buy | ALECTOR INC | $29,948,000 | -9.8% | 2,076,812 | +18.9% | 1.22% | +2.4% |
SRPT | Buy | SAREPTA THERAPEUTICS INC | $28,772,000 | -38.7% | 382,000 | +23.6% | 1.17% | -30.5% |
SEM | Sell | SELECT MED HLDGS CORP | $28,403,000 | -12.4% | 1,714,099 | -16.1% | 1.16% | -0.6% |
BPMC | Sell | BLUEPRINT MEDICINES CORP | $27,713,000 | -24.9% | 377,200 | -3.6% | 1.13% | -14.8% |
DBVT | DBV TECHNOLOGIES S Asponsored adr | $27,531,000 | +4.6% | 3,201,222 | 0.0% | 1.12% | +18.7% | |
TNDM | Buy | TANDEM DIABETES CARE INC | $26,797,000 | +172.4% | 454,334 | +197.9% | 1.09% | +209.6% |
SIEN | Sell | SIENTRA INC | $26,811,000 | -6.4% | 4,137,470 | -11.1% | 1.09% | +6.2% |
EDIT | EDITAS MEDICINE INC | $26,352,000 | -8.1% | 1,158,841 | 0.0% | 1.07% | +4.3% | |
PTC THERAPEUTICS INCnote 3.000% 8/1 | $25,902,000 | -6.0% | 24,877,000 | 0.0% | 1.06% | +6.7% | ||
DFBHU | DFB HEALTHCARE ACQUISTION COunit 01/30/2023 | $25,800,000 | -0.5% | 2,500,000 | 0.0% | 1.05% | +13.0% | |
AXGN | Buy | AXOGEN INC | $22,992,000 | +30.3% | 1,842,330 | +106.7% | 0.94% | +47.8% |
SWTX | New | SPRINGWORKS THERAPEUTICS INC | $22,783,000 | – | 1,050,888 | +100.0% | 0.93% | – |
XERS | Sell | XERIS PHARMACEUTICALS INC | $22,694,000 | -16.6% | 2,308,666 | -3.0% | 0.92% | -5.4% |
MOH | Buy | MOLINA HEALTHCARE INC | $21,621,000 | +0.7% | 197,056 | +31.4% | 0.88% | +14.3% |
RCKT | Buy | ROCKET PHARMACEUTICALS INC | $20,666,000 | +21.2% | 1,773,938 | +56.0% | 0.84% | +37.5% |
DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $20,185,000 | +47.3% | 594,725 | -2.1% | 0.82% | +67.3% |
ADUS | ADDUS HOMECARE CORP | $20,051,000 | +5.8% | 252,915 | 0.0% | 0.82% | +20.0% | |
ARVN | ARVINAS INC | $19,853,000 | -2.0% | 921,234 | 0.0% | 0.81% | +11.1% | |
MRTX | Sell | MIRATI THERAPEUTICS INC | $18,153,000 | -33.4% | 233,000 | -11.9% | 0.74% | -24.4% |
HUM | HUMANA INC | $17,130,000 | -3.6% | 67,000 | 0.0% | 0.70% | +9.4% | |
WVE | Buy | WAVE LIFE SCIENCES LTD | $16,583,000 | -5.0% | 807,727 | +20.7% | 0.68% | +7.8% |
ARDX | Sell | ARDELYX INC | $15,982,000 | +71.6% | 3,400,410 | -1.8% | 0.65% | +95.2% |
WRIGHT MED GROUP N Vnote 2.250%11/1 | $15,941,000 | -21.0% | 13,625,000 | 0.0% | 0.65% | -10.3% | ||
PTCT | PTC THERAPEUTICS INC | $15,929,000 | -24.8% | 471,000 | 0.0% | 0.65% | -14.7% | |
RETA | REATA PHARMACEUTICALS INCcl a | $15,817,000 | -14.9% | 197,000 | 0.0% | 0.64% | -3.4% | |
GLPG | GALAPAGOS NVspon adr | $15,420,000 | +18.4% | 101,010 | 0.0% | 0.63% | +34.4% | |
ANAB | Sell | ANAPTYSBIO INC | $14,886,000 | -51.2% | 425,443 | -21.3% | 0.61% | -44.6% |
DPLO | Sell | DIPLOMAT PHARMACY INC | $14,682,000 | -65.7% | 2,996,328 | -57.4% | 0.60% | -61.1% |
TPTX | Buy | TURNING POINT THERAPEUTICS I | $14,572,000 | +24.5% | 387,545 | +34.8% | 0.59% | +41.4% |
BOLD | AUDENTES THERAPEUTICS INC | $13,874,000 | -25.8% | 493,901 | 0.0% | 0.57% | -15.8% | |
SYRS | SYROS PHARMACEUTICALS INC | $13,172,000 | +12.1% | 1,268,946 | 0.0% | 0.54% | +27.3% | |
GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $13,008,000 | +5.2% | 268,100 | +14.1% | 0.53% | +19.4% |
AVDL | AVADEL PHARMACEUTICALS PLCsponsored adr | $11,325,000 | +44.0% | 2,722,241 | 0.0% | 0.46% | +63.3% | |
KNSA | Sell | KINIKSA PHARMACEUTICALS LTD | $10,842,000 | -38.9% | 1,274,086 | -2.8% | 0.44% | -30.6% |
KALV | Sell | KALVISTA PHARMACEUTICALS INC | $10,332,000 | -61.7% | 890,668 | -26.9% | 0.42% | -56.6% |
MNKKQ | Buy | MALLINCKRODT PUB LTD CO | $10,101,000 | -73.7% | 4,191,327 | +0.3% | 0.41% | -70.1% |
INGN | New | INOGEN INC | $9,182,000 | – | 191,660 | +100.0% | 0.37% | – |
GH | New | GUARDANT HEALTH INC | $8,043,000 | – | 126,000 | +100.0% | 0.33% | – |
BCRX | Sell | BIOCRYST PHARMACEUTICALS | $7,949,000 | -66.7% | 2,774,643 | -55.9% | 0.32% | -62.2% |
EHTH | Sell | EHEALTH INC | $7,347,000 | -72.6% | 110,000 | -64.6% | 0.30% | -68.8% |
ATRC | New | ATRICURE INC | $7,302,000 | – | 292,777 | +100.0% | 0.30% | – |
XFOR | Sell | X4 PHARMACEUTICALS INC | $7,165,000 | -15.5% | 563,741 | -0.2% | 0.29% | -3.9% |
AIMT | New | AIMMUNE THERAPEUTICS INC | $7,109,000 | – | 339,480 | +100.0% | 0.29% | – |
AVRO | New | AVROBIO INC | $7,060,000 | – | 500,000 | +100.0% | 0.29% | – |
BBIO | BRIDGEBIO PHARMA INC | $6,226,000 | -20.4% | 290,000 | 0.0% | 0.25% | -9.6% | |
TELIGENT INC NEWnote 4.750% 5/0 | $5,550,000 | +9.6% | 9,567,000 | 0.0% | 0.23% | +24.2% | ||
MDCO | MEDICINES COput | $5,000,000 | +37.1% | 100,000 | 0.0% | 0.20% | +55.7% | |
PRVB | New | PROVENTION BIO INC | $4,948,000 | – | 725,000 | +100.0% | 0.20% | – |
ABMD | New | ABIOMED INC | $4,910,000 | – | 27,600 | +100.0% | 0.20% | – |
FTSV | New | FORTY SEVEN INC | $4,815,000 | – | 750,000 | +100.0% | 0.20% | – |
IGMS | New | IGM BIOSCIENCES INC | $4,438,000 | – | 250,000 | +100.0% | 0.18% | – |
ALIM | Buy | ALIMERA SCIENCES INC | $4,000,000 | -25.7% | 7,062,607 | +16.7% | 0.16% | -16.0% |
AGLE | AEGLEA BIOTHERAPEUTICS INC | $3,845,000 | +12.3% | 500,046 | 0.0% | 0.16% | +27.6% | |
IDYA | Sell | IDEAYA BIOSCIENCES INC | $3,807,000 | -10.1% | 422,974 | -0.5% | 0.16% | +2.0% |
HARP | Sell | HARPOON THERAPEUTICS INC | $3,613,000 | -2.5% | 264,497 | -7.2% | 0.15% | +10.5% |
MOR | Sell | MORPHOSYS AGsponsored ads | $3,426,000 | -76.3% | 124,701 | -79.2% | 0.14% | -73.1% |
BDSI | BIODELIVERY SCIENCES INTL IN | $3,436,000 | -9.5% | 816,096 | 0.0% | 0.14% | +2.9% | |
STIM | Buy | NEURONETICS INC | $2,821,000 | +41.8% | 339,512 | +113.5% | 0.12% | +62.0% |
ITMR | ITAMAR MED LTDsponsored ads | $2,749,000 | -20.4% | 314,136 | 0.0% | 0.11% | -9.7% | |
ATEC | New | ALPHATEC HOLDINGS INC | $2,693,000 | – | 536,517 | +100.0% | 0.11% | – |
SYBX | SYNLOGIC INC | $2,537,000 | -74.8% | 1,107,643 | 0.0% | 0.10% | -71.5% | |
AGRX | New | AGILE THERAPEUTICS INC | $1,886,000 | – | 1,591,652 | +100.0% | 0.08% | – |
CSTL | New | CASTLE BIOSCIENCES INC | $1,673,000 | – | 92,477 | +100.0% | 0.07% | – |
ALPN | Sell | ALPINE IMMUNE SCIENCES INC | $1,611,000 | -8.0% | 406,926 | -2.2% | 0.07% | +4.8% |
VRAY | New | VIEWRAY INC | $1,098,000 | – | 378,623 | +100.0% | 0.04% | – |
EYEN | Sell | EYENOVIA INC | $729,000 | -43.5% | 197,069 | -34.3% | 0.03% | -34.8% |
NEOS | NEOS THERAPEUTICS INC | $475,000 | +14.7% | 320,993 | 0.0% | 0.02% | +26.7% | |
KMPH | New | KEMPHARM INC | $477,000 | – | 692,104 | +100.0% | 0.02% | – |
MNLO | Sell | MENLO THERAPEUTICS INC | $446,000 | -62.5% | 99,622 | -49.8% | 0.02% | -58.1% |
PRTO | PROTEON THERAPEUTICS INC | $318,000 | -37.6% | 1,224,899 | 0.0% | 0.01% | -27.8% | |
CNST | Sell | CONSTELLATION PHARMCETICLS I | $152,000 | -93.3% | 23,600 | -87.1% | 0.01% | -92.6% |
KIDS | Exit | ORTHOPEDIATRICS CORP | $0 | – | -32,000 | -100.0% | -0.04% | – |
PFNX | Exit | PFENEX INC | $0 | – | -394,255 | -100.0% | -0.10% | – |
ADPT | Exit | ADAPTIVE BIOTECHNOLOGIES COR | $0 | – | -70,000 | -100.0% | -0.12% | – |
SRNE | Exit | SORRENTO THERAPEUTICS INC | $0 | – | -2,091,461 | -100.0% | -0.20% | – |
ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -3,983,025 | -100.0% | -0.31% | – |
CHWY | Exit | CHEWY INCcl a | $0 | – | -261,337 | -100.0% | -0.33% | – |
INSP | Exit | INSPIRE MED SYS INC | $0 | – | -151,106 | -100.0% | -0.33% | – |
PHAS | Exit | PHASEBIO PHARMACEUTICALS INC | $0 | – | -851,005 | -100.0% | -0.40% | – |
ATNX | Exit | ATHENEX INC | $0 | – | -621,859 | -100.0% | -0.44% | – |
ANTM | Exit | ANTHEM INC | $0 | – | -53,000 | -100.0% | -0.54% | – |
SWAV | Exit | SHOCKWAVE MED INC | $0 | – | -312,146 | -100.0% | -0.64% | – |
NVTA | Exit | INVITAE CORP | $0 | – | -995,312 | -100.0% | -0.84% | – |
NVRO | Exit | NEVRO CORP | $0 | – | -386,000 | -100.0% | -0.90% | – |
STAA | Exit | STAAR SURGICAL CO | $0 | – | -876,512 | -100.0% | -0.92% | – |
Exit | EXACT SCIENCES CORPnote 1.000% 1/1 | $0 | – | -15,000,000 | -100.0% | -0.93% | – | |
NTRA | Exit | NATERA INC | $0 | – | -1,002,834 | -100.0% | -0.99% | – |
Exit | DEXCOM INCnote 0.750% 5/1 | $0 | – | -20,000,000 | -100.0% | -1.15% | – | |
Exit | INSULET CORPnote 1.375%11/1 | $0 | – | -36,650,000 | -100.0% | -1.87% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
EHEALTH INC | 25 | Q3 2020 | 2.0% |
INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
MYLAN NV | 23 | Q3 2020 | 6.2% |
PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
3 | 2024-03-19 |
4 | 2024-03-19 |
4 | 2024-03-12 |
3 | 2024-03-08 |
4 | 2024-02-16 |
13F-HR | 2024-02-14 |
4 | 2024-02-08 |
3 | 2024-02-01 |
4 | 2023-11-21 |
13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.